1 study found for:    14766260 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
Condition: Sarcoma
Intervention: Drug: gemcitabine hydrochloride

Indicates status has not been verified in more than two years